Modified Yersinia therapy(Boehringer Ingelheim International GmbH)
N/A
Report date: 2024/06/12 17:53:26
Base Information
Drug NameModified Yersinia therapy(Boehringer Ingelheim International GmbH)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A
Develop Information
Active CompaniesBoehringer Ingelheim International Gmbh
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A